Dilated coronary arteries in a 2-month-old with RIT1-associated Noonan syndrome: a case report.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
02 01 2023
Historique:
received: 05 01 2022
accepted: 22 12 2022
entrez: 2 1 2023
pubmed: 3 1 2023
medline: 5 1 2023
Statut: epublish

Résumé

Noonan Syndrome is caused by variants in a variety of genes found in the RAS/MAPK pathway. As more causative genes for Noonan Syndrome have been identified, more phenotype variability has been found, particularly congenital heart defects. Here, we report a case of dilated coronary arteries in a pediatric patient with a RIT1 variant to add to the body of literature around this rare presentation of Noonan Syndrome.  CASE PRESENTATION: A 2-month-old female was admitted due to increasing coronary artery dilation and elevated inflammatory markers. Rapid whole genome sequencing was performed and a likely pathogenic RIT1 variant was detected. This gene has been associated with a rare form of Noonan Syndrome and associated heart defects. Diagnosis of the RIT1 variant also gave reassurance about the patient's cardiac findings and allowed for more timely discharge as she was discharged to home the following day.  CONCLUSIONS: This case highlights the importance of the association between dilated coronary arteries and Noonan syndrome and that careful cardiac screening should be advised in patients diagnosed with Noonan syndrome. In addition, this case emphasizes the importance of involvement of other subspecialities to determine a diagnosis. Through multidisciplinary medicine, the patient was able to return home in a timely manner with a diagnosis and the reassurance that despite her dilated coronary arteries and elevated inflammatory markers there was no immediate concern to her health.

Sections du résumé

BACKGROUND
Noonan Syndrome is caused by variants in a variety of genes found in the RAS/MAPK pathway. As more causative genes for Noonan Syndrome have been identified, more phenotype variability has been found, particularly congenital heart defects. Here, we report a case of dilated coronary arteries in a pediatric patient with a RIT1 variant to add to the body of literature around this rare presentation of Noonan Syndrome.  CASE PRESENTATION: A 2-month-old female was admitted due to increasing coronary artery dilation and elevated inflammatory markers. Rapid whole genome sequencing was performed and a likely pathogenic RIT1 variant was detected. This gene has been associated with a rare form of Noonan Syndrome and associated heart defects. Diagnosis of the RIT1 variant also gave reassurance about the patient's cardiac findings and allowed for more timely discharge as she was discharged to home the following day.  CONCLUSIONS: This case highlights the importance of the association between dilated coronary arteries and Noonan syndrome and that careful cardiac screening should be advised in patients diagnosed with Noonan syndrome. In addition, this case emphasizes the importance of involvement of other subspecialities to determine a diagnosis. Through multidisciplinary medicine, the patient was able to return home in a timely manner with a diagnosis and the reassurance that despite her dilated coronary arteries and elevated inflammatory markers there was no immediate concern to her health.

Identifiants

pubmed: 36593444
doi: 10.1186/s12887-022-03818-w
pii: 10.1186/s12887-022-03818-w
pmc: PMC9806447
doi:

Substances chimiques

ras Proteins EC 3.6.5.2
RIT1 protein, human EC 3.6.1.-

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1

Informations de copyright

© 2022. The Author(s).

Références

Tex Heart Inst J. 2011;38(3):318-9
pubmed: 21720486
Sci Transl Med. 2019 Apr 24;11(489):
pubmed: 31019026
NPJ Genom Med. 2018 Apr 4;3:10
pubmed: 29644095
Am J Hum Genet. 2019 Oct 3;105(4):719-733
pubmed: 31564432
J Cutan Med Surg. 2013 May-Jun;17(3):212-8
pubmed: 23673306
Mol Genet Genomic Med. 2019 Apr;7(4):e00581
pubmed: 30784236
Pediatr Radiol. 2016 Mar;46(3):422-5
pubmed: 26515448
Am J Med Genet A. 2014 Sep;164A(9):2310-6
pubmed: 24939608
Front Pediatr. 2022 Sep 07;10:934808
pubmed: 36160792
Pediatr Cardiol. 2010 Feb;31(2):242-9
pubmed: 20024653
Eur J Med Genet. 2017 Jun;60(6):299-302
pubmed: 28347726
Hum Genet. 2016 Feb;135(2):209-22
pubmed: 26714497

Auteurs

Claudia V Aniol (CV)

College of Osteopathic Medicine, Rocky Vista University, Parker, CO, USA.

Jeremy W Prokop (JW)

Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Corewell Health Office of Research, Grand Rapids, MI, USA.

Surender Rajasekaran (S)

Department of Pharmacology and Toxicology, College of Human Medicine, Michigan State University, East Lansing, MI, USA.
Corewell Health Office of Research, Grand Rapids, MI, USA.
Pediatric Critical Care Medicine, Helen DeVos Children's Hospital, Grand Rapids, MI, USA.

Spencer Pageau (S)

Corewell Health Office of Research, Grand Rapids, MI, USA.

Sydney K Elizer (SK)

Department of Internal Medicine and Pediatrics, Helen DeVos Children's Hospital, Grand Rapids, MI, USA.

Elizabeth A VanSickle (EA)

Medical Genetics, Corewell Health and Helen DeVos Children's Hospital, 25 Michigan St NE, Suite 2000, Grand Rapids, MI, 49503, USA.

Caleb P Bupp (CP)

Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA. caleb.bupp@spectrumhealth.org.
Medical Genetics, Corewell Health and Helen DeVos Children's Hospital, 25 Michigan St NE, Suite 2000, Grand Rapids, MI, 49503, USA. caleb.bupp@spectrumhealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH